[go: up one dir, main page]

FI20115135A0 - Mikrofibrilloidun selluloosan tulehduksia estävä vaikutus - Google Patents

Mikrofibrilloidun selluloosan tulehduksia estävä vaikutus

Info

Publication number
FI20115135A0
FI20115135A0 FI20115135A FI20115135A FI20115135A0 FI 20115135 A0 FI20115135 A0 FI 20115135A0 FI 20115135 A FI20115135 A FI 20115135A FI 20115135 A FI20115135 A FI 20115135A FI 20115135 A0 FI20115135 A0 FI 20115135A0
Authority
FI
Finland
Prior art keywords
microfibrillated cellulose
inflammatory action
inflammatory
action
microfibrillated
Prior art date
Application number
FI20115135A
Other languages
English (en)
Swedish (sv)
Other versions
FI126259B (fi
FI20115135L (fi
FI20115135A (fi
Inventor
Kaisa Herranen
Mia Lohman
Original Assignee
Upm Kymmene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43629806&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI20115135(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Upm Kymmene Corp filed Critical Upm Kymmene Corp
Priority to FI20115135A priority Critical patent/FI126259B/fi
Publication of FI20115135A0 publication Critical patent/FI20115135A0/fi
Priority to EP12716475.4A priority patent/EP2672950B1/en
Priority to US13/984,831 priority patent/US9018189B2/en
Priority to ES12716475.4T priority patent/ES2661582T3/es
Priority to JP2013552997A priority patent/JP6386226B2/ja
Priority to NO12716475A priority patent/NO2672950T3/no
Priority to DK12716475.4T priority patent/DK2672950T3/en
Priority to PCT/FI2012/050129 priority patent/WO2012107648A1/en
Publication of FI20115135L publication Critical patent/FI20115135L/fi
Publication of FI20115135A publication Critical patent/FI20115135A/fi
Publication of FI126259B publication Critical patent/FI126259B/fi
Application granted granted Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polymers & Plastics (AREA)
FI20115135A 2011-02-11 2011-02-11 Mikrofibrilloitu selluloosa käytettäväksi erityisesti atooppisen ihotulehduksen ja psoriasiksen hoidossa FI126259B (fi)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FI20115135A FI126259B (fi) 2011-02-11 2011-02-11 Mikrofibrilloitu selluloosa käytettäväksi erityisesti atooppisen ihotulehduksen ja psoriasiksen hoidossa
PCT/FI2012/050129 WO2012107648A1 (en) 2011-02-11 2012-02-10 Anti-inflammatory effect of microfibrillated cellulose
ES12716475.4T ES2661582T3 (es) 2011-02-11 2012-02-10 Efecto antiinflamatorio de la celulosa microfibrilada
US13/984,831 US9018189B2 (en) 2011-02-11 2012-02-10 Anti-inflammatory effect of microfibrillated cellulose
EP12716475.4A EP2672950B1 (en) 2011-02-11 2012-02-10 Anti-inflammatory effect of microfibrillated cellulose
JP2013552997A JP6386226B2 (ja) 2011-02-11 2012-02-10 微小繊維状セルロースの抗炎症効果
NO12716475A NO2672950T3 (fi) 2011-02-11 2012-02-10
DK12716475.4T DK2672950T3 (en) 2011-02-11 2012-02-10 Anti-inflammatory effect of microfibrillated cellulose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20115135A FI126259B (fi) 2011-02-11 2011-02-11 Mikrofibrilloitu selluloosa käytettäväksi erityisesti atooppisen ihotulehduksen ja psoriasiksen hoidossa

Publications (4)

Publication Number Publication Date
FI20115135A0 true FI20115135A0 (fi) 2011-02-11
FI20115135L FI20115135L (fi) 2012-08-12
FI20115135A FI20115135A (fi) 2012-08-12
FI126259B FI126259B (fi) 2016-09-15

Family

ID=43629806

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20115135A FI126259B (fi) 2011-02-11 2011-02-11 Mikrofibrilloitu selluloosa käytettäväksi erityisesti atooppisen ihotulehduksen ja psoriasiksen hoidossa

Country Status (8)

Country Link
US (1) US9018189B2 (fi)
EP (1) EP2672950B1 (fi)
JP (1) JP6386226B2 (fi)
DK (1) DK2672950T3 (fi)
ES (1) ES2661582T3 (fi)
FI (1) FI126259B (fi)
NO (1) NO2672950T3 (fi)
WO (1) WO2012107648A1 (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI126513B (fi) * 2011-01-20 2017-01-13 Upm Kymmene Corp Menetelmä lujuuden ja retention parantamiseksi ja paperituote
US20140134218A1 (en) 2012-11-09 2014-05-15 Johnson & Johnson Consumer Companies, Inc. Rinse-off skin care compositions containing cellulosic materials
US20140134217A1 (en) 2012-11-09 2014-05-15 Johnson & Johnson Consumer Companies, Inc. Leave-on compositions containing cellulose materials
US9370478B2 (en) 2012-11-09 2016-06-21 Johnson & Johnson Consumer Inc. Skin care compositions containing cotton and citrus-derived materials
FI126109B (fi) 2013-02-22 2016-06-30 Upm Kymmene Corp Nanofibrillipolysakkaridi käytettäväksi kuroutumisen ja arpeutumisen hallitsemiseen ja estoon
FR3016296B1 (fr) * 2014-01-14 2021-06-25 Feeligreen Dispositif pour l'electrostimulation et/ou l'iontophorese
FI129421B (fi) 2014-03-12 2022-02-15 Maelkki Yrjoe Nanoselluloosan ja sen esiasteiden valmistus ja käyttö
FI125758B (fi) 2014-12-22 2016-02-15 Upm Kymmene Corp Menetelmä nanofibrilliselluloosan hydrogeelin viskositeetin vähentämiseksi
FI129934B (fi) 2015-02-13 2022-11-15 Upm Kymmene Corp Ommellanka, menetelmä ommellangan valmistamiseksi ja sen käyttö
DK3228329T3 (da) * 2016-04-06 2022-08-29 Upm Kymmene Corp Fremgangsmåde til fremkomst af et lægemiddel, omfattende nanofibrillar cellulose og et lægemiddel
JP7237837B2 (ja) 2016-09-30 2023-03-13 ノヴァフラックス・インコーポレイテッド 洗浄および汚染除去用組成物
AU2019249171B2 (en) 2018-04-03 2025-02-20 Novaflux, Inc. Cleaning composition with superabsorbent polymer
EP3833362A4 (en) * 2018-08-06 2022-05-18 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd CELLULOSE-BASED TOPICAL FORMULATIONS
US12064495B2 (en) 2019-10-03 2024-08-20 Protegera, Inc. Oral cavity cleaning composition, method, and apparatus
WO2021067872A1 (en) 2019-10-03 2021-04-08 Novaflux, Inc. Oral cavity cleaning composition, method, and apparatus

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4378381A (en) 1980-10-31 1983-03-29 International Telephone And Telegraph Corporation Suspensions containing microfibrillated cellulose
JPS6239507A (ja) * 1985-08-13 1987-02-20 Daicel Chem Ind Ltd 皮膚手入れ用化粧料
DE4328871A1 (de) 1993-08-27 1995-03-02 Beiersdorf Ag Mittel gegen empfindliche, hyperreaktive Hautzustände, atopische Dermatiden, Pruritus, Psoriasis Prurigo, Photodermatosen und Ichthyosis
FR2730252B1 (fr) 1995-02-08 1997-04-18 Generale Sucriere Sa Cellulose microfibrillee et son procede d'obtention a partir de pulpe de vegetaux a parois primaires, notamment a partir de pulpe de betteraves sucrieres.
FR2744632B1 (fr) 1996-02-13 1998-03-27 Oreal Utilisation d'une suspension aqueuse de microfibrilles d'origine naturelle pour la preparation de compositions cosmetiques ou dermatologiques, compositions cosmetiques ou dermatologiques et applications
JPH09275424A (ja) 1996-04-04 1997-10-21 Matsushita Electric Ind Co Ltd 送信装置
SK3599A3 (en) 1996-07-15 2000-04-10 Rhodia Chimie Sa Composition containing cellulose nanofibrils, the preparation method thereof, an aqueous suspension containing cellulose nanofibrils and the use of this composition and suspension
FR2769836B1 (fr) * 1997-10-21 2000-03-10 Rhodia Chimie Sa Utilisation de nanofibrilles de cellulose essentiellement amorphes associees a au moins un compose organique polyhydroxyle dans des formulations cosmetiques
FR2822679A1 (fr) 2001-03-30 2002-10-04 Oreal Composition cosmetique comprenant un melange de fibres
JP4961772B2 (ja) * 2005-03-01 2012-06-27 Ｊｎｃ株式会社 硫酸化セルロース及びその塩から選ばれた化合物並びに皮膚炎治療剤
WO2007027849A2 (en) * 2005-08-31 2007-03-08 Board Of Regents, The University Of Texas System Multiribbon nanocellulose as a matrix for wound healing
WO2009031620A1 (ja) * 2007-09-05 2009-03-12 Taiyokagaku Co., Ltd. 水溶性電界紡糸シート
US8410125B2 (en) * 2007-11-05 2013-04-02 Yagna Limited Sulfonated precursors of thymidine for the treatment of epithelial hyperplasias

Also Published As

Publication number Publication date
FI126259B (fi) 2016-09-15
WO2012107648A1 (en) 2012-08-16
JP2014505093A (ja) 2014-02-27
ES2661582T3 (es) 2018-04-02
JP6386226B2 (ja) 2018-09-05
FI20115135L (fi) 2012-08-12
EP2672950B1 (en) 2017-12-13
DK2672950T3 (en) 2018-02-12
EP2672950A1 (en) 2013-12-18
NO2672950T3 (fi) 2018-05-12
FI20115135A (fi) 2012-08-12
US9018189B2 (en) 2015-04-28
US20140045785A1 (en) 2014-02-13

Similar Documents

Publication Publication Date Title
FI20115135A (fi) Mikrofibrilloidun selluloosan tulehduksia estävä vaikutus
MX373103B (es) Ciclopropilaminas como inhibidores de desmetilasa específica de lisina 1 (lsd1).
UA117958C2 (uk) Похідні хіноксаліну, корисні як модулятори кінази fgfr
PH12016500953A1 (en) Tricyclic compounds as anticancer agents
TR201816379T4 (tr) DNA-PK inhibitörleri.
UA108101C2 (xx) Похідні n3-заміщених n1-сульфоніл-5-фторпіримідинонів
CR20130410A (es) Compuestos y composiciones como inhibidores de la trk
BR112015020389A2 (pt) compostos carbazol úteis como inibidores de bromodomínio
EA201300730A1 (ru) Производные индазолилтриазола
EA201591728A1 (ru) Гетероциклические соединения и способы их применения
CR20140106A (es) Compuestos y composiciones como inhibidores de la quinasa c-kit
UY33883A (es) Novedosos derivados heterocíclicos
EA201491817A1 (ru) Терапевтическое применение продуктов из косточек винограда шардоне
EA201691032A1 (ru) Производные изохромена в качестве ингибиторов фосфоинозитид-3-киназ
EA201490423A1 (ru) СПОСОБЫ И КОМПОЗИЦИИ, ОТНОСЯЩИЕСЯ К p62, ДЛЯ ЛЕЧЕНИЯ И ПРОФИЛАКТИКИ РАКА
IN2015DN01151A (fi)
BR112014028042A2 (pt) inibidores de nampt
BR112019021867A2 (pt) Compostos de fenil-2-hidroxi-acetilamino-2-metil-fenil
BR112015001697A2 (pt) formulações de clomazona
BR112016006388A2 (pt) inibidor seletivo da fosfatidilinositol 3-quinase gama
CA2929436C (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
UY35747A (es) Derivados sustituidos de fenilalanina
CO7101239A2 (es) Composiciones derivadas de la quitosana
UY35745A (es) Derivados sustituidos de fenilalanina
DOP2015000176A (es) Compuestos de azetidiniloxifenilpirrolidina

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 126259

Country of ref document: FI

Kind code of ref document: B